skip page navigationOregon State University

Craig D. Williams, Pharm.D.

Associate Professor
Department of Pharmacy Practice

Contact Information

College of Pharmacy
Oregon Health & Science University
3303 SW Bond Ave., CH12C
Portland, OR 97239
Phone: 503-494-1598
williacr@ohsu.edu

Education

Residency, Cedars-Sinai Medical Center, 1994–1995
Pharm.D., University of California at San Francisco, 1990–1994
Pre-Pharmacy, University of California at Los Angeles, 1987–1990

Positions and Employment

Assistant Professor of Pharmacy Practice, Purdue University School of Pharmacy, 1995–2002.
Associate Professor of Pharmacy Practice, Purdue University School of Pharmacy, 2002–2006.
Adjunct Associate Professor of Medicine, Indiana Univesity School of Medicine, 2002–2006.
Associate Professor of Pharmacy Practice, Oregon State University College of Pharmacy, 2006–present.

Other experience and professional membership

Clinical Pharmacist, Department of Pharmaceutical Services, Wishard Memorial Hospital, Indianapolis, Indiana, 1995–2006.
Clinical Staff, Wishard Cardiology Clinic, 1998–2006.
American Heart Association, Circulation and Basic Science Council, 1998–present.
Member, Wishard Health Services Pharmacy and Therapeutics Committee, 1999–2006.
Editorial Advisor, Clinical Therapeutics, 1999–2001.
Member, American Society of Health System Pharmacists (ASHP), 1999–2003.
Member, American College of Clinical Pharmacy, 2000–present.
Editorial Advisory Board, Pharmacists Letter, 2001–present.
Chair, Medication Use and Evaluation (MUE) committee, Wishard Health Services, 2001–2006.
Co-chair, Wishard Health Services Pharmacy and Therapeutics Committee, 2003–2006.
Member, Exempt/Expedited Institutional Review Board, Indiana University-Purdue University at Indianapolis (IUPUI), 2003–2006.
Reviewer, Journal of the American Pharmacists Association (JAPhA), 2004–present.
Member, American College of Clinical Pharmacy Case Studies Task Force, 2005–present.
Member, National Lipid Association, 2005–present.
Associate Editor, Diabetes Forecast, 2006–present.

Research

Ongoing Research Support

Medical School Grant, Merck Inc., 2002–present
Clinical trial of statins in patients with low HDL cholesterol

Completed Research Support

Kinetic study of enoxaparin dosing in chronic kidney disease
National Kidney Foundation; Hellman (PI)
2002–2005

Jointly funded by Clarian Health Centers, Pfizer and Sanofi-Aventis to establish city-wide lipid working group in effort to increase collaborative efforts on dyslipidemia in Indianapolis, Indiana
Multi-source Educational Center Grant
2003–2006

3-9% recurring annual salary support for clinical center working on several national, multi-center studies
Asthma Clinical Research Center Grant
2000–2006

Selected Publications

Williams CD. Costs and outcomes of switching amlodipine to felodipine. American Journal of Health-System Pharmacy. 2000;57:2287-2288.

Williams CD. Amlodipine PREVENTS angina, not atherosclerosis. Pharmacotherapy. 2002;22:400-402.

Williams CD. Potency of inhaled corticosteroid fails to predict reduced Emergency Department visits. Peer-reviewed research letter Archives of Internal Medicine. 2003;163:247-249.

Williams CD. Progression of renal disease. In: Pharmacotherapy Self Assessment Program (PSAP). 4th ed. 2003;9:261-297.

Vasavada N, Williams CD, Hellman R. Ethylene glycol intoxication: case report and pharmacokinetic perspectives. Pharmacotherapy. 2003;23(12):1652-58.

Jacob S, Williams CD, Deeg M. Fenofibrate, simvastatin and rhabdomyolysis. Diabetes Care. 2005;28(5):1258-1259.

Schellhase EM, Chen JT, Jordan J, Kania DS, Overholser BR, Shepler BM, Sowinski KM, Williams CD, Pharmacology In: Magee DJ, Zachazewski JE, Quillen WS, eds. Musculoskeletal Rehabilitation Series, Volume II, Scientific Foundations and Principles of Practice. 2nd ed. Philadelphia: W.B. Saunders; 2006.

Antons K, Williams C, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. American Journal of Medicine. 2006;119:400-409.

Williams CD. CKD and Cardiovascular Disease. Pathophysiology and Management Pharmacotherapy Self Assessment Program (PSAP). Ed. Accepted for publication.

Marrs J, Williams C, Ito M. Omacor effects on serum lipids and clinical outcomes. American Journal of Cardiology. 2007;99:145.